User:Mr. Ibrahem/Copanlisib

Copanlisib, sold under the brand name Aliqopa, is a medication used to treat follicular lymphoma. It is used in those who have failed other treatments. It is given by injection into a vein.

Common side effects include high blood sugar, diarrhea, weakness, high blood pressure, low white blood cells, nausea, pneumonia, and low platelets. Other side effects may include infection and pneumonitis. Use in pregnancy may harm the baby. It is a PI3-kinase inhibitor.

Copanlisib was approved for medical use in the United States in 2017. As of 2022 it is not approved in either the United Kingdom or Europe. In the United States it costs about 5,000 USD per dose as of 2022.